Roche Tests MiniMed, Brings Marketing Muscle To Disetronic Insulin Delivery
This article was originally published in The Gray Sheet
Executive Summary
Medtronic MiniMed will have to contend with the emergence of Disetronic's insulin infusion pumps, backed by Roche's extensive sales presence, on the U.S. diabetes care market